Understanding Biologic Therapy Switching Patterns in Psoriasis and Psoriatic Arthritis Patients
October 22nd 2023This study aimed to evaluate the association between the disease burden of psoriasis and the switching of systemic biologic therapies in patients with both psoriasis and psoriatic arthritis.
Preparing Your Patient to Ask for ADA Workplace Accommodations
October 16th 2023Sometimes patients are unsure of what they can request from an employer for their skin conditions, and advice from a trusted clinician about reasonable accommodations can serve as an extra step to build their confidence to continue their career.
New Phase 3 Data on Long-Term Efficacy of Upadacitinib in Atopic Dermatitis Presented at EADV
October 11th 2023The data presents compelling evidence for the sustained efficacy and safety of the oral JAK1 inhibitor in the treatment of moderate to severe atopic dermatitis over an extended 140-week period.